Evidence map›Paper›PMID 19834493›Full record

ArticleCell death and differentiation2010

Disruption of PPARgamma signaling results in mouse prostatic intraepithelial neoplasia involving active autophagy.

M Jiang, S Fernandez, W G Jerome, Y He, X Yu, H Cai, B Boone, Y Yi, M A Magnuson, P Roy-Burman and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell death and differentiation, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 55 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

M JiangDepartment of Urologic Surgery, A-1302 MCN, Vanderbilt University Medical Center, Nashville, TN 37232-2765, USA. ming.jiang.1@vanderbilt.edu
S Fernandez
W G Jerome
Y He
X Yu
H Cai
B Boone
Y Yi
M A Magnuson
P Roy-Burman
R J Matusik
S B Shappell
S W Hayward
Tennessee Oncology · USVanderbilt University Medical Center · USBioarray Genetics (United States) · USTennessee Department of Health · USUniversity of Southern California · US

Funding

Tumor Immunology and Microenvironment Research ProgramP30CA068485 · NCI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI MATTHEW J TYSKA · 1995 to 2026
$172.8M
Translational Analysis CoreP30DK058404 · NIDDK · VANDERBILT UNIVERSITY MEDICAL CENTER · PI RICHARD M. PEEK · 2002 to 2026
$29.9M
Shop Module CoreP30EY008126 · NEI · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Kevin L Schey · 1989 to 2026
$19.6M
PATHOGENESIS OF HUMAN PROSTATE CARCINOMASR01CA059705 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ROY-BURMAN, PRADIP · 1993 to 2012
$7.3M
CONTROL OF PROSTATE-SPECIFIC GENE EXPRESSIONR01DK055748 · NIDDK · VANDERBILT UNIVERSITY · PI MATUSIK, ROBERT J. · 1999 to 2013
$4.1M
Paracrine Regulation of BPH PathogenesisR01DK067049 · NIDDK · VANDERBILT UNIVERSITY · PI HAYWARD, SIMON W · 2004 to 2013
$2.6M
Bone matrix proteins in prostate cancer progressionR01CA113392 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI ROY-BURMAN, PRADIP · 2005 to 2010
$1.6M
Paracrine Regulation of BPH PathogeneisR56DK067049 · NIDDK · VANDERBILT UNIVERSITY · PI HAYWARD, SIMON W · 2009 to 2009
$370k
NCI NIH HHS CA68485NCI NIH HHS P30 CA068485NCI NIH HHS P30 CA68485NCI NIH HHS R01 CA059705NCI NIH HHS R01 CA113392NCI NIH HHS R01 CA59705NEI NIH HHS P30 EY008126NEI NIH HHS P30 EY08126NIDDK NIH HHS DK20539NIDDK NIH HHS DK58404NIDDK NIH HHS P30 DK058404NIDDK NIH HHS P30 DK58404NIDDK NIH HHS R01 DK055748NIDDK NIH HHS R01 DK067049NIDDK NIH HHS R01 DK67049NIDDK NIH HHS R56 DK067049
6 · The paper itself

Abstract

Peroxisome proliferator-activated receptor-gamma (PPARgamma) regulates the interface between cellular lipid metabolism, redox status and organelle differentiation. Conditional prostatic epithelial knockout of PPARgamma in mice resulted in focal hyperplasia which developed into mouse prostatic intraepithelial neoplasia (mPIN). The grade of PIN became more severe with time. Electron microscopy (EM) showed accumulated secondary lysosomes containing cellular organelles and debris suggestive of autophagy. Consistent with this analysis the autophagy marker LC-3 was found to be upregulated in areas of PIN in PPARgamma KO tissues. We selectively knocked down PPARgamma2 isoform in wild-type mouse prostatic epithelial cells and examined the consequences of this in a tissue recombination model. Histopathologically grafted tissues resembled the conditional PPARgamma KO mouse prostates. EM studies of PPARgamma- and PPARgamma2-deficient epithelial cells in vitro were suggestive of autophagy, consistent with the prostatic tissue analysis. This was confirmed by examining expression of beclin-1 and LC-3. Gene expression profiling in PPARgamma-/gamma2-deficient cells indicated a major dysregulation of cell cycle control and metabolic signaling networks related to peroxisomal and lysosomal maturation, lipid oxidation and degradation. The putative autophagic phenotypes of PPARgamma-deficient cells could be rescued by re-expression of either gamma1 or gamma2 isoform. We conclude that disruption of PPARgamma signaling results in autophagy and oxidative stress during mPIN pathogenesis.

Indexed as

AnimalsAutophagyCell LineEpithelial CellsGene Expression ProfilingHypoglycemic AgentsMaleMiceMice, SCIDMice, TransgenicMolecular Sequence DataPhenotypePPAR gammaProstateProstatic Intraepithelial NeoplasiaProstatic NeoplasmsHypoglycemic AgentsPPAR gammaProtein IsoformsRosiglitazoneThiazolidinediones

Identifiers

PMID19834493
PMCPMC2821953
OpenAlexW1980224065

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.